Blog
A biotech VC’s prescription for what ails pharma
How can we balance innovation and affordability in prescription drugs? Peter Kolchinsky has some ideas.
Is FDA's annual new drug count a nothingburger?
FDA approved 46 new drugs so far in 2017. But are they the drugs we need?
Biotech and medtech pitch decks: The best guides, tips, and tricks
The best pitch deck resources and guides for biotech and medtech entrepreneurs (updated 7/30/2022).
What Is Theranos's Business Model, Anyway?
There are plenty of ways to win in diagnostics - Theranos just needs to pick one.
Technology, end-of-life care, and 'Being Mortal'
Atul Gawande's recent book on end-of-life care is inspiring and thought-provoking - and an important must-read for tech experts, entrepreneurs, and investors.
Why oncology companies should care about drug adherence
Many companies think adherence isn't an issue in cancer care. They're wrong.
New drugs less effective than old ones? Not so fast...
Q: Are we really making worse drugs now than we used to, as suggested by a recent high-profile news article? A: No. And I'll explain why.